Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion.
Thomas
S R
SR
Jaffe
A
A
Geddes
D M
DM
Hodson
M E
ME
Alton
E W
EW
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000328:Adult; D000584:Amiloride / Q000494:pharmacology; D001993:Bronchodilator Agents / Q000494:pharmacology; D018118:Chloride Channels / Q000187:drug effects / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism* / Q000494:pharmacology; D003550:Cystic Fibrosis / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004232:Diuretics / Q000494:pharmacology; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects / Q000502:physiology; D006720:Homozygote; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009154:Mutation / Q000235:genetics*; D012189:Retrospective Studies
D001993:Bronchodilator Agents; C505032:CFTR protein, human; D018118:Chloride Channels; D002712:Chlorides; D004232:Diuretics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000584:Amiloride; D000255:Adenosine Triphosphate; D007545:Isoproterenol